STOCK TITAN

iAnthus Announces Ruling by the Ontario Superior Court of Justice

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

iAnthus Capital Holdings, Inc. (CSE: IAN) (OTCPK: ITHUF) announced that Justice Penny of the Ontario Superior Court granted relief to Secured Noteholders in a recent application. The ruling extends the Outside Date in the restructuring support agreement until all regulatory approvals for their Recapitalization Transaction are met. iAnthus is reviewing the decision and considering an appeal, having 30 days to do so. Regulatory approvals are still outstanding in Florida, Massachusetts, New York, and Maryland.

Positive
  • Justice Penny extended the Outside Date for the restructuring support agreement.
  • iAnthus retains the right to appeal the court's decision.
Negative
  • Regulatory approvals in multiple states are still outstanding, delaying the Recapitalization Transaction.
  • Potential delays in operations may impact business and financial outcomes due to reliance on regulatory consent.

NEW YORK and TORONTO, Oct. 13, 2021 /PRNewswire/ - iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, provides an update on its response to the Secured Noteholders' application (the "Application") iAnthus previously announced via news release on August 27, 2021 and that was the subject of an update on September 27, 2021 (the "September News Release").  On October 12, 2021, Justice Penny released his decision granting the Secured Noteholders' relief sought in the Application (the "Decision"). Specifically, Justice Penny granted the declaration sought by the Secured Noteholders and ordered that: "the Outside Date in the restructuring support agreement has been and is extended to the date on which any regulatory approval or consent condition to implementation of the Plan is satisfied or waived."

The Company is reviewing the Decision carefully and is considering the merits of an appeal.  iAnthus has the right to appeal the Decision to the Ontario Court of Appeal on or before 30 days from the release of the decision.

As described in the September News Release, the Secured Noteholders are subject to a stay that, among other things, prevents any party to the restructuring support agreement dated July 10, 2020 (the "RSA") from advancing or impeding the regulatory process for the closing of the transactions contemplated by the RSA (the "Recapitalization Transaction") until 48 hours after the release of Justice Penny's decision.  At the conclusion of the stay, iAnthus will continue to satisfy all of its obligations and pursue all of its rights under the RSA.  Prior regulatory approvals in Florida, Massachusetts, New York and Maryland necessary to close the Recapitalization Transaction are still outstanding.

A copy of the September News Release is available under iAnthus' SEDAR profile at www.sedar.com and under the Company's profile on the US Securities and Exchange Commission's website at www.sec.gov.

About iAnthus

iAnthus owns and operates licensed cannabis cultivation, processing and dispensary facilities throughout the United States. For more information, visit www.iAnthus.com.

COVID-19 Risk Factor

The Company may be impacted by business interruptions resulting from pandemics and public health emergencies, including those related to COVID-19. An outbreak of infectious disease, a pandemic, or a similar public health threat, such as the recent outbreak of COVID-19, or a fear of any of the foregoing could adversely impact the Company by causing operating, manufacturing, supply chain, and project development delays and disruptions, labor shortages, travel, and shipping disruption and shutdowns (including as a result of government regulation and prevention measures). It is unknown whether and how the Company may be affected if such a pandemic persists for an extended period of time, including as a result of the waiver of regulatory requirements or the implementation of emergency regulations to which the Company is subject. Although the Company has been deemed essential and/or has been permitted to continue operating its facilities in the states in which it cultivates, processes, manufactures, and sells cannabis during the pendency of the COVID-19 pandemic, there is no assurance that the Company's operations will continue to be deemed essential and/or will continue to be permitted to operate. The Company may incur expenses or delays relating to such events outside of its control, which could have a material adverse impact on its business, operating results, financial condition, and the trading price of the Company's common shares.

Forward Looking Statements

Statements in this news release contain forward-looking statements. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of management, are not guarantees of performance and are subject to significant risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors, including those set forth in Company's reports that it files from time to time with the SEC and the Canadian securities regulators which you should review including, but not limited to, the Company's Annual Report on Form 10-K filed with the SEC. When used in this news release, words such as "will", "could", "plan", "estimate", "expect", "intend", "may", "potential", "believe", "should" and similar expressions, are forward-looking statements. Forward-looking statements may include, without limitation, statements relating to the Company's financial performance, business development and results of operations, the Decision and the timing and outcome of the closing of the recapitalization transaction contemplated in the RSA.

These forward-looking statements should not be relied upon as predictions of future events, and the Company cannot assure you that the events or circumstances discussed or reflected in these statements will be achieved or will occur. If such forward-looking statements prove to be inaccurate, the inaccuracy may be material. You should not regard these statements as a representation or warranty by the Company or any other person that it will achieve its objectives and plans in any specified timeframe, or at all. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The Company disclaims any obligation to publicly update or release any revisions to these forward-looking statements, whether as a result of new information, future events or otherwise, after the date of this news release or to reflect the occurrence of unanticipated events, except as required by law.

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cision View original content:https://www.prnewswire.com/news-releases/ianthus-announces-ruling-by-the-ontario-superior-court-of-justice-301399379.html

SOURCE iAnthus Capital Holdings, Inc.

FAQ

What was the recent court ruling concerning iAnthus (ITHUF)?

On October 12, 2021, Justice Penny ruled in favor of Secured Noteholders, extending the Outside Date for iAnthus's restructuring support agreement until necessary regulatory approvals are met.

What is the significance of the restructuring support agreement for iAnthus (ITHUF)?

The restructuring support agreement is crucial for iAnthus as it relates to their Recapitalization Transaction, which requires various regulatory approvals to proceed.

What are the potential impacts of the court's decision on iAnthus (ITHUF)?

The decision could delay the Recapitalization Transaction due to outstanding regulatory approvals in states like Florida and New York, potentially affecting iAnthus's financial condition.

Is iAnthus (ITHUF) considering an appeal after the court ruling?

Yes, iAnthus is reviewing the court's decision and considering the merits of an appeal within 30 days.

IANTHUS CAPITAL HLDG ORD

OTC:ITHUF

ITHUF Rankings

ITHUF Latest News

ITHUF Stock Data

33.39M
3.61B
7.34%
85.18%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto